In addition to the change towards a pro-tumor phenotype, macrophages also incur a metabolic change, driven by NF-kB, which acts by increasing glycolysis, with a consequent increase in lactate production that enhances KRAS-driven tumor growth and contributes to the reduction in T-cells [113]. The gene discussed is NFKB1; the disease is neoplasm.